HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
    • FUTURE Conference
  • Awards
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • Subscribe

Inogen Appoints Eric Pauls as Vice President of Sales for North America
The appointment is the latest of several executive hires this year.

September 11, 2024 by Laurie Watanabe

Inogen Inc. (Nasdaq: INGN), a provider of home respiratory care products, announced the appointment of Eric Pauls as vice president of sales for North America, effective this month.

Pauls previously served as chief customer officer at RQM+.

“As we advance towards the introduction of Simeox to the U.S. market, Eric’s experience with the respiratory business will help us facilitate a strong and effective rollout,” Gregoire Ramade, chief commercial officer for Inogen, said in a press release.

The home medical equipment (HME) manufacturer has made additional executive appointments in 2024.

In March, Inogen hired Michael Bourque to serve as the company’s chief financial officer. And in July, the California-based company announced the appointment of Kevin P. Smith as general counsel and executive vice president of business development.

Inogen is an international medical technology company specializing in respiratory products for home use. In August, Inogen reported a 6.1% increase in Q2 2024 revenue, reaching $88.8 million, driven by higher demand and new customers, particularly in international and domestic business-to-business (B2B) sales.

During the company’s Q2 earnings call, CEO Kevin R. Smith said he anticipates 3% to 5% growth for 2024, projecting full-year revenue between $325 million and $330 million, and that the company’s strategic focus includes innovation in personal oxygen concentrators and expansion in B2B channels.

Related Articles Read More >

Briefly: Year-End Legislation Takes Shape in the Senate; US Loses Measles Elimination Status
Featuring the United States Senate, the Pan American Health Organization and the Centers for Disease Control.
Numotion Names Presidents of CRT, Adaptive Solutions Businesses
Two Numotion veterans were promoted after the company was acquired by Hanger Inc.
CMS Offers States 6-Month ‘Hold Harmless’ Period for Medicaid Work Requirements
The period would extend through June 30, 2027.
CMS: CRUSH Proposed Rule Would Save Nearly $90 Billion in 10 Years
The proposed rule includes provisions for Medicare, Medicare Advantage, Medicaid and “bad actor” agents and brokers.

Get the free newsletter

Home Healthcare Softare

Subscribe to HME Business for industry & product news, trends and resources.
HME Business Directory
HME Podcasts
HME Business
  • Mobility Management
  • Senior Housing News
  • Home Health Care News
  • Skilled Nursing News
  • Hospice News
  • Behavioral Health Business
  • About HME Business
  • Contact Us

Copyright © 2026 Arrowfly LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly
Privacy Policy | Advertising | About Us

Search HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
    • FUTURE Conference
  • Awards
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • Subscribe